In this round-up, we look at some of the latest updates and insights from functional ingredients suppliers, including leadership changes at Sami-Sabinsa, PhytoGaia’s plans for a trial that examines multi-carotenoids’ benefits for weight management, Synbio...
In our monthly nutra regulatory round-up, we look at the latest regulatory announcements happening across APAC, including China’s food industry association planning to set industry standards for electrolyte drinks, Taiwan’s harsher penalties for firms...
Food Standards Australia New Zealand (FSANZ) has started a public consultation regarding the use of 2’-fucosyllactose (2’-FL) produced by Korean firm Advanced Protein Technologies (AP Tech) in infant formulas.
The ingredients division of the Dutch dairy co-op said its 2’-fucosyllactose ingredient has been approved for use in both infant formulas as well as young children products.
Kirin-owned Kyowa Hakko Bio will be collaborating with the Agency for Science, Technology and Research (A*STAR) in Singapore to advance research on human milk oligosaccharides (HMOs) and explore their potential applications, particularly in the areas...
Food Standards Australia New Zealand (FSANZ) has approved dsm-firmenich’s four human milk oligosaccharides (HMOs), including the mixture of 2’-fucosyllactose (2’-FL) and difucosyllactose (DFL), for use in infant formula products.
Nestle has launched in China its first growing up formula containing human milk oligosaccharides (HMOs), namely 2'-fucosyllactose (2'FL) and lacto-N-(neo)tetraose (LNnT).
In our monthly nutra regulatory round-up, we take a closer look at India's nutraceutical regulatory approach through an interview with a former director from Food Safety and Standards Authority of India (FSSAI), Malaysia's advisory on oral aloe...
From the approval of postbiotics for use in health supplements in India to Blackmores' NPD plans and China's approval of human milk oligosaccharides (HMOs) for use in infant formula, here are the most-read stories in October 2023.
Human milk oligosaccharides (HMOs) are now officially permitted for use in China’s infant formula, with two multinationals, namely IFF and dsm-firmenich, as well as local dairy giant Mengniu, announcing that they have received approvals in the past week.
Junlebao Dairy Group has launched its Nutrition Science Strategy, aiming to strengthen the science behind its products, as well as to identify novel functional ingredients.
The probiotics market in South Korea, the hottest ingredients trending in Vietnam’s infant formula market, and nutrition brand’s omnichannel retail strategies are some of our most-read health and nutrition trends stories for this year.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
FrieslandCampina said its 2’-fucosyllactose trademarked Aequival has been approved by Australia’s and New Zealand’s authorities for use in infant milk formula, and that it is on track in expanding its human milk oligosaccharide (HMO) portfolio.
Breastfeeding mothers with a higher intake of vegetables, vitamins and metal elements produced more human milk oligosaccharides (HMOs) in their breast milk, according to an observational study funded by Abbott Nutrition R&D Center in Shanghai.
Bacteria species that can feed on a wide range of human milk oligosaccharides (HMOs) are known to grow and dominate an infant’s gut microbiota, but this is not always the case, with a new research showing how the order of bacteria exposure could be more...
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
A novel probiotics encapsulation technology, H&H Group’s pioneering research on HMObiotics, curcumin’s benefits on cognitive health are some of the stories covered in this round-up of new scientific findings.
Major nutrition company Health and Happiness (H&H Group) is pioneering research on how the right pairings of human milk oligosaccharides (HMOs) and probiotics – a novel category known as ‘HMObiotics’ – could bring about health benefits for consumers...
The human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) is generally the most abundant in colostrum, however, this is not the case for colostrum produced by mothers who are Malaysian Chinese, Japanese, and Samoans, said a review.
Infant formula companies are exploring new functional ingredients such as human milk oligosaccharides (HMOs), various milk bases such as goat milk and sheep milk and securing organic claims, according to experts who spoke at our Growth Asia Series 2021.
Taiwan has become the latest APAC region to approve the use of 2’-fucosyllactose (2’-FL) – a human milk oligosaccharide (HMO) – in nutrition products for infant and young children, with firms hopeful of further sector growth as more authorities permit...
Existing research on human milk oligosaccharides (HMOs) is only at the tip of the iceberg and there are vast opportunities for developing new pre/probiotics/synbiotics with HMOs, says an expert specialising in this field.
